Suppr超能文献

西班牙北部口腔鳞状细胞癌中人乳头瘤病毒的患病率

Prevalence of human papillomavirus in oral squamous cell carcinomas in northern Spain.

作者信息

Rodríguez-Santamarta Tania, Rodrigo Juan Pablo, García-Pedrero Juana M, Álvarez-Teijeiro Saúl, Ángeles Villaronga M, Suárez-Fernández Laura, Alvarez-Argüelles Marta E, Astudillo Aurora, de Vicente Juan Carlos

机构信息

Department of Oral and Maxillofacial Surgery, Hospital Universitario Central de Asturias (HUCA), C/Carretera de Rubín, s/n, 33011, Oviedo, Asturias, Spain.

Department of Otolaryngology, Hospital Universitario Central de Asturias (HUCA), C/Carretera de Rubín, s/n, 33011, Oviedo, Asturias, Spain.

出版信息

Eur Arch Otorhinolaryngol. 2016 Dec;273(12):4549-4559. doi: 10.1007/s00405-016-4152-9. Epub 2016 Jun 24.

Abstract

The aim of this study was to analyze the prevalence of high-risk HPV in oral squamous cell carcinoma (OSCC) in a northern Spanish population, as well as to ascertain the prognostic role of p16 expression. The examination samples were collected from paraffin tissue blocks, from 125 patients surgically treated between 1996 and 2007. All cases were histologically evaluated, and the presence of HPV was assessed by p16 and p53immunohistochemistry followed by DNA detection by in situ hybridization (ISH) and polymerase chain reaction (PCR) amplification using the combination of consensus primers MY11/GP6 + . Fourteen cases (11 %) were p16-immunopositive, and p53 was scored positive in 73 cases (58 %). Five cases (4 %) showed a simultaneous p16-positive and p53-negative immunostaining. ISH was negative in all the cases. Among the p16INK4a-immunopositive cases, PCR amplification failed to reveal HPV DNA in any tumor samples. There were no statistically significant differences in any clinical or pathological characteristics of the patients regarding p16 expression. T classification, neck-node metastasis, and clinical stage showed outcome relevance. However, no significant differences in cause-specific survival based on p16INK4a were observed. We did not find any high-risk HPV types in our patients, thus, are unlikely that HPV has an important role in the etiology of OSCC. p16INK4a protein was neither an accurate marker of HPV infection nor a prognosis marker in OSCC.

摘要

本研究旨在分析西班牙北部人群口腔鳞状细胞癌(OSCC)中高危型人乳头瘤病毒(HPV)的流行情况,并确定p16表达的预后作用。检测样本取自石蜡组织块,来自1996年至2007年间接受手术治疗的125例患者。所有病例均进行了组织学评估,通过p16和p53免疫组织化学评估HPV的存在情况,随后通过原位杂交(ISH)和聚合酶链反应(PCR)扩增(使用通用引物MY11/GP6 +组合)进行DNA检测。14例(11%)病例p16免疫阳性,73例(58%)病例p53评分阳性。5例(4%)病例同时显示p16阳性和p53阴性免疫染色。所有病例ISH均为阴性。在p16INK4a免疫阳性病例中,PCR扩增未在任何肿瘤样本中检测到HPV DNA。患者的任何临床或病理特征在p16表达方面均无统计学显著差异。T分类、颈部淋巴结转移和临床分期显示与预后相关。然而,基于p16INK4a的特定病因生存率未观察到显著差异。我们在患者中未发现任何高危型HPV类型,因此,HPV在OSCC病因中不太可能起重要作用。p16INK4a蛋白既不是HPV感染的准确标志物,也不是OSCC的预后标志物。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验